The cause of [Kawasaki syndrome](10.1086/509509), a severe acute childhood disease, is proving to be a real mystery. In the 40 years since the syndrome was first described, its cause has been ascribed to 30 different infectious agents. In 2005, Jeffrey Kahn (Yale University, New Haven, CT, USA) and colleagues suggested a link with human coronavirus (HCoV)-NL63, but since then other studies have not provided the hoped-for confirmation.

Kathryn Holmes' group at the University of Colorado Health Science Center (Denver, CO, USA) have published their results from a blinded, case-control retrospective study. "Although HCoV-NL63 was circulating in the children with Kawasaki syndrome who were tested over a 7-month period, the prevalence of infection with the virus was not greater in patients with Kawasaki syndrome than in control subjects", she reported. The authors concluded that there is no evidence for an aetiological association between HCoV-NL63 and Kawasaki syndrome.

"I find this study very convincing", commented Jane Burns (University of California, San Diego School of Medicine, La Jolla, CA, USA). Burns likes the idea of looking at large numbers of longitudinally collected respiratory samples from Kawasaki syndrome patients using broadly cross-hybridising PCR primers for different viral groups. "This work from one of the leading coronavirus labs in the country puts the final nail in the coffin of the coronavirus theory of Kawasaki disease", she added. Li-Min Huang, (Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan) agreed that "HCoV-NL63 might not be the answer we are looking for", but he also pointed out that "it is not unreasonable to associate HCoV-NL63 with Kawasaki disease because the receptor ACE2 is present on many relevant cell types". He also stressed that the original case-control approach taken by Kahn\'s group was not inappropriate.

Kahn considers that the current study was "well conducted" and accepts that several studies have failed to confirm his group\'s initial findings. "However, the association between Kawasaki disease and HCoV-NL63, or any other pathogen for that matter, must rely on techniques other than just nucleic acid amplification of respiratory secretions", he said. Kahn believes that Kawasaki disease might be triggered by one or more infectious agents that may be long gone by the time of disease presentation. He remains confident that "serological assays and/or the application of the tool of molecular biology to pathological specimens may ultimately lead to determining the cause(s) of Kawasaki disease".
